Food and Drug Administration
Anesthetic and Life Support Drugs Advisory Committee
January 31, 2002
Slides
Ensuring Proper Use and Curbing Abuse of Opiods: An Industry perspective, J David Haddox, DDS, MD, Purdue Pharma, LP ppt htm
Findings from the Drug Abuse Warning Network, Narcotic Analgesics, Judy K ball, PhD, MPA, Office of Applied Studies, Substance Abuse and Mental Health Services Administration ppt htm
Abuse Liability and Drug Scheduling: The Role of the FDA, Deborah Leiderman, MD, FDA ppt htm
An Epidemiologic Overview of Prescription Drug Misuse, Howard D Chilcoat, Tracy Dusablon, Department of Mental Hygiene, John Hopkins University, School of Hygiene and Public Health ppt htm
Substance Abuse Issues in Chronic Pain Management, Steven D Passik, PhD, Oncology Symptom Control and Research, Community Cancer Care, Inc. ppt htm